Titlebook: Biomaterials in Artificial Organs; J. P. Paul,J. D. S. Gaylor,T. Gilchrist Book 1984 Palgrave Macmillan, a division of Macmillan Publisher

昏暗

The 1983 Adam Thomson Lecture The Role Of Biomaterials In The Application Of Artificial Organs,laborative fields held of easing human suffering, and in particular of prolonging active life, and secondly because I was convinced that in view of the sense of commitment of all concerned outstanding success would be achieved’.

Generic-Drug

Principles And Practice Of Membrane Plasmapheresis, the early fifties (Adams et al., 1952). The continuous centrifuge was developed by Judson during the following decade (Millward and Hoeltge, 1982). Although the preparative (euphemistically termed ‘donor’) application was sizeable, the therapeutic use of plasmapheresis remained limited and speciali

轉(zhuǎn)向

Clinical Experience With Capd,mmonly in the form of continuous ambulatory peritoneal dialysis (CAPD) but also (10%–20%) in the form of continuous cycling peritoneal dialysis (CCPD). Approximately half of the patients are situated in the United States, most of the other half in Europe, and approximately 600 patients in Australia

DRILL

Continuous Ambulatory Peritoneal Dialysis: A Discussion Of Some Problems,out 10% of the total dialysis population in Australia, Europe and The United States were treated with CAPD (Nolph et al., 1983). The potential cost-saving and the inherent simplicity of the method are important factors in this development, but there is also a wide range of studies reporting clinical

小爭(zhēng)吵

debacle

,Discussion Following Chapters 2–5,sease to be treated. He believed that there was a list of 55 diseases for which plasmapheresis had been tried with probably not more than one at best for which it had any value. Gurland disagreed by stating that the list of diseases was over 100 and referred to a Panel Discussion at the 1983 ASAIO m

Apogee

Declining Utility Of Home Haemodialysis For Uraemia,e world whose kidneys have failed. Whereas in 1960 the only available treatment for renal failure was institutionally based maintenance haemodialysis (except for those rare patients with a monozygotic twin willing to serve as a kidney donor), in 1983, patient and physician may select from a potentia

meritorious

Feedback Monitoring For Sodium And Water Transfer During Haemodialysis,0–145 mEq of Na/1 is also transported. This tremendous negative sodium transfer must be immediately compensated. This is accomplished by a shift of Na coming by diffusion from dialysate at a rate which depends upon the gradient concentration between the dialysate and plasma.

Spinal-Fusion

olfction